auto-schweiz / Schlagwort(e): Sonstiges Auto-Markt mit zehn Prozent Plus im April 02.05.2024 / 15:13 CET/CEST Neue Personenwagen April 2024 Bern, 2. Mai 2024 Der derzeitigen Konjunkturschwäche zum Trotz ist der Markt für neue Personenwagen der Schweiz und des Fürstentums Liechtenstein im April um 10,4 Prozent gewachsen. Insgesamt wurden 20'040 Neuimmatrikulationen registriert, nach 18'150 im Vorjahresmonat, der allerdings noch von Lieferschwierigkeiten und Teilemangel geprägt war. Nach dem besten April am Schweizer Auto-Markt seit 2021 ist die kumulierte Zahl an Neuwagen se...
auto-schweiz / Mot-clé(s) : Autres Hausse de dix pour cent du marché automobile en avril 02.05.2024 / 15:13 CET/CEST Nouvelles voitures de tourisme en avril 2024 Berne, 2 mai 2024 Malgré la faiblesse actuelle de la conjoncture, le marché des voitures de tourisme neuves en Suisse et dans la principauté du Liechtenstein a augmenté de 10,4 % en avril. Les nouvelles immatriculations se montent à 20'040, contre 18'150 au même mois de l'année précédente, qui était toutefois encore marqué par des difficultés de livraison et une pénurie de pièces. Après le meilleur mois d'avril sur...
Team Member Feedback Earns HealthEquity Workplace Culture Recognition For the fourth consecutive year, team members' feedback has propelled HealthEquity to be recognized for cultural excellence DRAPER, Utah, May 02, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the nation’s largest Health Savings Account (HSA) custodian has received a Culture Excellence Award by Top Workplaces for the fourth consecutive year. "Our teammates deserve all the credit when it comes to this award,” said Cheryl King, executive vice president and chief human resource officer. “They have embraced o...
Kforce Inc. Announces its Participation at the Baird 2024 Global Consumer, Technology and Services Conference TAMPA, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- Kforce Inc. (NASDAQ: KFRC), a solutions firm that specializes in technology and professional staffing services, today announced that management will participate at Baird’s Global Consumer, Technology, and Services Conference on June 5, 2024, in New York City. A link to the webcast and presentation, which is currently scheduled for 4:20pm, can be accessed at under “Events and Presentations.” A replay of the webcast will be available...
Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) New role enhances company’s strong leadership team and solidifies commitment to ongoing clinical innovation DOYLESTOWN, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced the appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer (CMO) of...
Information on share capital and voting rights - April 2024 Information on share capital and voting rights April 2024 Statement made in accordance with article L. 233-8 II of the French commercial Code and articles 221-1 2 ° f) and 223-16 of the AMF Regulations. May 2nd, 2024 Statement made by: Nexans S.A.Registered office : 4 Allée de l’Arche - 92400 CourbevoieRCS Nanterre 393 525 852Regulated market of Euronext Paris (Compartment A) Date Total number of shares Total number of...
Information mensuelle relative au nombre d'actions et de droits de vote - Avril 2024 Information mensuelle relative au nombre d’actions et de droits de voteAvril 2024 Déclaration faite en application de l'article L. 233-8 II du code de commerce et des articles 221-1 2° f) et 223-16 du règlement général de l’AMF. Le 2 mai 2024 Société déclarante : Nexans S.A.Siège social : 4 Allée de l’Arche – 92400 CourbevoieRCS Nanterre 393 525 852Marché réglementé d’Euronext Paris (Compartiment A) Date Nombre d’acti...
Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 ATLANTA, May 02, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including (“FM”) and (“LC”), announced today that it will report first quarter 2024 financial results on Thursday, May 9, 2024 before the open of the financial markets. Management will also host a webcast and conference call on May 9, 2024 at 8:30 a.m. ET to discuss the results and provide a corp...
CORRECTION: LXP Industrial Trust Reports First Quarter 2024 Results WEST PALM BEACH, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by LXP Industrial Trust (NYSE:LXP), please note that the percentage underneath the "Subsequent Events" header was changed from "8%" to "26.9%". The corrected release follows: LXP Industrial Trust (“LXP”) (NYSE:LXP), a real estate investment trust focused on single-tenant warehouse/distribution real estate investments, today announced results for the quarter ended March 31, 2024. First Quarter 2024 Highlights...
Kelowna, British Columbia--(Newsfile Corp. - May 2, 2024) - F3 Uranium Corp. (TSXV: FUU) (OTCQB: FUUFF) ("F3 Uranium" or the "Company") is pleased to announce that due to significant investor demand, the Company has increased the gross proceeds of its previously announced private placement (the "Underwritten Offering") to C$9,000,000. Under the revised Underwritten Offering, the Underwriters (as defined herein) have agreed to purchase for resale 16,071,429 flow-through units of the Company (each, a "FT Unit") at a price of C$0.56 per FT Unit (the "Offering Price") on a "bought deal" basis. Red...
Moody's Ratings ("Moody's") commented on CVS Health Corporation's (Baa2 stable) continuing pressure in its Medicare Advantage business, which prompted a significant downward revision in 2024 earnings guidance. These events are credit negative because of the impact on CVS's financial leverage, with g...
Lassila & Tikanoja plc: Managers' transactions - Laura Lares Lassila & Tikanoja plcStock Exhange Release2.5.2024 4.05 pm Lassila & Tikanoja Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Laura LaresPosition: Member of the Board/Deputy memberIssuer: Lassila & Tikanoja OyjLEI: 743700Z9Z54VGHZA0028Notification type: INITIAL NOTIFICATIONReference number: 60955/4/4____________________________________________Transaction date: 2024-05-02Outside a trading venueInstrument type: SHAREISIN: FI0009010854Nature of transaction: ...
Lassila & Tikanoja Oyj: Ilmoitus johdon liiketoimista - Laura Lares Lassila & Tikanoja Oyj Pörssitiedote 2.5.2024 klo 16.05 Lassila & Tikanoja Oyj - Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Laura LaresAsema: Hallituksen jäsen/varajäsenLiikkeeseenlaskija: Lassila & Tikanoja OyjLEI: 743700Z9Z54VGHZA0028Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 60955/4/4____________________________________________Liiketoimen päivämäärä: 2024-05-02Kauppapaikka ei sovelluInstrumenttityyppi: OSAKEISIN: FI0009010854Liiketoimen luonne: OSAKEPALKKION VASTAANOT...
Lassila & Tikanoja plc: Managers' transactions - Pasi Tolppanen Lassila & Tikanoja plcStock Exhange Release2.5.2022 4.05 pm Lassila & Tikanoja Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Pasi TolppanenPosition: Member of the Board/Deputy memberIssuer: Lassila & Tikanoja OyjLEI: 743700Z9Z54VGHZA0028Notification type: INITIAL NOTIFICATIONReference number: 60958/4/4____________________________________________Transaction date: 2024-05-02Outside a trading venueInstrument type: SHAREISIN: FI0009010854Nature of transac...
Lassila & Tikanoja plc: Managers' transactions - Sakari Lassila Lassila & Tikanoja plcStock Exhange Release2.5.2024 4.05 pm Lassila & Tikanoja Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Sakari LassilaPosition: Member of the Board/Deputy memberIssuer: Lassila & Tikanoja OyjLEI: 743700Z9Z54VGHZA0028Notification type: INITIAL NOTIFICATIONReference number: 60964/4/4____________________________________________Transaction date: 2024-05-02Outside a trading venueInstrument type: SHAREISIN: FI0009010854Nature of transac...
Lassila & Tikanoja Oyj: Ilmoitus johdon liiketoimista - Sakari Lassila Lassila & Tikanoja Oyj Pörssitiedote 2.5.2024 klo 16.05 Lassila & Tikanoja Oyj - Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Sakari LassilaAsema: Hallituksen jäsen/varajäsenLiikkeeseenlaskija: Lassila & Tikanoja OyjLEI: 743700Z9Z54VGHZA0028Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 60964/4/4____________________________________________Liiketoimen päivämäärä: 2024-05-02Kauppapaikka ei sovelluInstrumenttityyppi: OSAKEISIN: FI0009010854Liiketoimen luonne: OSAKEPALKKION VAS...
Del Taco Opens Eighth Location in the Sunshine State The leading Mexican QSR chain continues its Florida Panhandle expansion with a new location in DeFuniak Springs DEFUNIAK SPRINGS, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- , the nation’s second-largest Mexican quick service restaurant*, announced today the opening of its new Fresh Flex location at 2760 S. Hwy 331. It is the second restaurant for franchise organization, Consolidated Taco Holdings, and uses the all-new Fresh Flex layout, which features a bold, modernized design and innovative layout changes to optimize the guest experienc...
FAT Brands Expands Partnership with Six Flags, Brings Third Restaurant Brand to Iconic Parks Hurricane Grill & Wings to debut at Six Flags Great Escape Lodge LOS ANGELES, May 02, 2024 (GLOBE NEWSWIRE) -- , parent company of Hurricane Grill & Wings and 17 other restaurant concepts, announces their latest brand to enter the legendary Six Flags properties. the Florida-born wing brand known for its laid-back environment and award-winning wings, will debut at Six Flags Great Escape Lodge in Queensbury, New York this summer. The latest opening underscores FAT Brands and Six Flags’ dynamic pa...
Outlook Therapeutics® to Present at the Retina World Congress 2024 ISELIN, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases in the US and the EU, today announced it will present at the being held May 9-12, 2024 in Fort Lauderdale, FL. Details for the presentations are as follows: Session: Retina UnpluggedPanelist: Russell Trenary, President and Chief Executive OfficerDate and Time: Thursday, May 9, 2024...
Lassila & Tikanoja Oyj: Managers' Transactions - Teemu Kangas-Kärki Lassila & Tikanoja plc Stock exchange release 2 May 2024 4.02 pm Lassila & Tikanoja Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Teemu Kangas-Kärki Position: Member of the Board/Deputy member Issuer: Lassila & Tikanoja Oyj LEI: 743700Z9Z54VGHZA0028 Notification type: INITIAL NOTIFICATION Reference number: 60949/5/4 ____________________________________________ Transaction date: 2024-05-02 Out...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.